Insider Selling: Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $678,200.00 in Stock

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares of the company’s stock, valued at $115,381,623.44. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Simulations Plus Stock Down 1.7 %

Shares of NASDAQ SLP opened at $35.58 on Friday. Simulations Plus, Inc. has a twelve month low of $24.00 and a twelve month high of $51.22. The stock’s 50 day moving average price is $30.65 and its 200-day moving average price is $32.45. The company has a market capitalization of $714.80 million, a PE ratio of 88.95 and a beta of 0.82.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors have recently bought and sold shares of SLP. First Horizon Advisors Inc. lifted its stake in Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after purchasing an additional 370 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. nVerses Capital LLC lifted its stake in Simulations Plus by 1,100.0% in the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after purchasing an additional 1,100 shares during the last quarter. Quantbot Technologies LP purchased a new position in Simulations Plus in the third quarter valued at approximately $59,000. Finally, US Bancorp DE lifted its stake in Simulations Plus by 37.0% in the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after purchasing an additional 1,343 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Wall Street Analysts Forecast Growth

SLP has been the subject of a number of recent research reports. KeyCorp boosted their price objective on Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. BTIG Research cut their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. Stephens assumed coverage on Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 target price on the stock. Finally, StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Simulations Plus has a consensus rating of “Moderate Buy” and an average price target of $49.40.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.